Losing Weight With PCOS for Fertility: Realistic Approaches

If you have PCOS and an elevated BMI, you have probably been told (often without much help) that you need to lose weight before trying to conceive. You are tired of being prescribed willpower as a treatment plan. You may be staring at PCOS weight-loss supplement marketing, or considering keto, or wondering whether a GLP-1 is the right call. This post is the honest version of the losing weight with PCOS for fertility conversation, written by a clinician who has had it many times.

The honest summary, before the detail. For PCOS with elevated BMI, a sustained 5 to 10 percent body weight reduction over months has the strongest evidence base for restoring ovulation and improving fertility outcomes. There is no proven weight-loss supplement for PCOS outside of inositol (modest effect) and clinician-prescribed metformin or GLP-1 receptor agonists. Crash dieting and "detox" protocols are not preconception-appropriate. The plan that works is durable, person-first, and sometimes runs in parallel with starting treatment rather than waiting for a target weight.

This post is also one of the most emotionally loaded topics in the library. I want to name that up front. The data I am about to walk through are real, and the language we use to talk about them matters. Person-first, anti-shame, evidence-led: that is the only honest way to do this.

What the losing weight with PCOS for fertility evidence supports

A 5 to 10 percent reduction in body weight in PCOS with elevated BMI is associated with several specific things that matter for fertility.

It restores ovulation in a meaningful fraction of previously anovulatory women. Legro and colleagues' randomised trial of preconception interventions in infertile women with PCOS shown that lifestyle-driven weight loss of this magnitude improved ovulation and pregnancy outcomes.⁷

It improves insulin resistance, lowers HOMA-IR, and improves the androgen profile. The 2023 International Evidence-based PCOS Guideline endorses this target explicitly and walks through the supporting evidence.¹

It improves the chance of spontaneous conception and the response to ovulation induction (letrozole or clomiphene) when these are needed.

The Lim Cochrane review on lifestyle changes in PCOS supports the same conclusion from a different angle.³ Lifestyle programmes that produce sustained weight reduction in this range improve metabolic and reproductive outcomes. Moran and colleagues' AE-PCOS Society position statement, written for clinicians, recommends 5 to 10 percent weight reduction as the actionable lifestyle target where BMI is elevated.²

The crucial point that gets lost in clinic conversations: improvement is not contingent on reaching "normal" BMI. The 5 to 10 percent threshold is the actionable target, and the benefits accrue within that range. You do not need to be a different size to be more fertile.

What "weight loss with PCOS is harder" actually means

I want to address this honestly because it is true on average, and saying so is not an excuse, it is information.

PCOS involves a pattern of insulin resistance and a small but measurable reduction in resting metabolic rate compared to non-PCOS controls. There may be differences in appetite regulation. For many people, a complicated psychological history with weight and food makes restrictive interventions actively risky. It is genuinely harder, on average, than weight loss without PCOS.

But "harder" is not "impossible." The same trial data showing the difficulty also shows that consistent, structured approaches work. What changes for PCOS is the type of approach. Severe caloric restriction tends to backfire, with greater regain and more menstrual disruption. Moderate insulin-aware dietary patterns combined with resistance training, and sometimes pharmacological support, tend to produce more durable results.

It is also worth saying clearly: this is a population at elevated risk of disordered eating. Aggressive caloric restriction can be more harmful than helpful, and the conversation about food and weight in PCOS needs to be held with that in mind.

What actually works, in order of yield

The interventions with the most evidence, roughly ordered by yield.

1. Sustainable dietary pattern that lowers postprandial insulin

A Mediterranean-pattern diet with low glycaemic load, sufficient protein (1.2 to 1.6 g/kg body weight), and high fibre is the dietary pattern with the most evidence in PCOS. The order of food on the plate matters: protein and fibre before carbohydrate at each meal produces lower postprandial glucose and insulin excursions, which is a high-yield free behaviour change.

Avoid extreme caloric restriction (sustained below 1200 kcal/day in most adults). The evidence for sustained very-low-calorie diets in PCOS is poor, and the regain rate is steep. See PCOS diet and fertility and the Mediterranean diet and TTC.

2. Resistance training plus moderate aerobic activity

Resistance training preserves and builds lean mass during weight loss, which matters for insulin sensitivity and resting metabolic rate. Two to three structured resistance sessions per week, plus around 150 minutes of moderate aerobic activity, is the target in the 2023 PCOS guideline.¹ See exercise and TTC, how much is too much.

A daily 30-minute walk after dinner is the highest-yield single movement behaviour I prescribe for PCOS. It lowers postprandial glucose, it is durable, it compounds with the dietary changes, and it is easier to sustain than gym work for most readers.

3. Sleep, mental health, and behavioural support

Short sleep is independently linked to weight gain and insulin resistance. Structured behavioural support (cognitive behavioural therapy, motivational interviewing, group programmes) consistently outperforms willpower-only approaches in trial data. If you have access to a dietitian or a structured PCOS programme, that is usually a better investment than another supplement. See sleep, stress, and fertility.

4. Insulin-sensitising medication

Metformin (typically 1500 to 2000 mg/day extended-release) produces modest weight effects in PCOS and improves insulin sensitivity. It is preferred preconception because there is the largest body of safety data in pregnancy of any of the metabolic medications used in PCOS. The Cochrane review of insulin-sensitising drugs supports its use.¹

Inositol contributes modestly to insulin sensitivity and is well tolerated. See myo-inositol and PCOS.

5. GLP-1 receptor agonists

This is the medication class that most readers of this post in 2026 are either already on or considering, so it deserves direct treatment.

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) produce significant weight loss in adults with elevated BMI, with or without diabetes. The STEP trial of once-weekly semaglutide showed a roughly 15 percent average weight reduction in non-diabetic adults with overweight or obesity over 68 weeks.⁵ Specific evidence in PCOS is growing. Several small trials show improvements in weight, insulin sensitivity, and menstrual regularity.

Clinically, they are a reasonable option in non-pregnant women with elevated BMI and PCOS who have not achieved the 5 to 10 percent target with lifestyle and metformin. The catch is preconception timing. Current consensus is that GLP-1s should be stopped at least 2 months before TTC, and they should not be used during pregnancy. The relevant literature on GLP-1 receptor agonist use and reproductive health is evolving, and the safety database in pregnancy is too small to support continued use.⁷

If you are on a GLP-1 and planning to try in the next 6 to 12 months, book a specific conversation with your prescriber. Cover the timing of the stop, the regain pattern to expect, and the bridge plan (often metformin and continued lifestyle work). Discuss whether a pause and TTC, or a longer GLP-1 course followed by TTC, makes more sense for your case. This is one of those decisions that benefits from being planned, not improvised.

6. Bariatric surgery

Considered for severely elevated BMI (typically 40 or above, or 35 or above with metabolic comorbidity) where other approaches have failed.⁶ Bariatric surgery can restore ovulation and fertility in PCOS, with specific timing rules: most guidelines recommend 12 to 24 months of weight stability post-operatively before conception, and ongoing nutrient monitoring (B12, folate, iron, calcium, vitamin D) is essential. This is outside the scope of this post; if you are considering it, the bariatric and fertility teams need to be in the conversation together.

What does NOT work as marketed

The flip side of the honest list is the honest "skip this" list. I am going to be specific because the search results for "best weight loss supplements for women with PCOS" are dominated by products that do not have the evidence behind their claims.

"Best weight loss supplements for women with PCOS": Outside of inositol (modest effect) and clinician-prescribed metformin or GLP-1, there is no proven weight-loss supplement for PCOS. Berberine has some preliminary insulin-resistance data and is sometimes positioned as a "natural metformin," but it is not interchangeable with metformin clinically, and the evidence base is thinner. Discuss with your clinician rather than self-prescribing.

Apple cider vinegar, "fat-burning" tea, garcinia cambogia, raspberry ketones, green coffee bean extract, "metabolism boosters," "PCOS detox" formulas: none of these have credible PCOS trial data. The marketing budget on these products is large and the evidence base is not.

Crash dieting: Very-low-calorie diets, prolonged fasting protocols beyond evidence-based time-restricted eating, fad protocols: short-term weight loss, steep regain rate, possible negative metabolic and menstrual effects, and preconception-inappropriate. The 5 to 10 percent target is not achieved by 30-day extreme protocols; it is achieved by 6 to 12 months of sustainable change.

"Detox" or "cleanse" protocols for PCOS: No evidence. Skip.

How to set the 5 to 10 percent target

Practical mechanics.

Calculate 5 percent and 10 percent of your current body weight in kilograms. Write those numbers down. Those are your targets for the next 6 to 12 months, not BMI 25.

Aim for a sustainable rate of 0.25 to 0.5 kg per week. Faster than that increases regain risk and, in some people, disrupts the endocrine system you are trying to support.

Plan over 3 to 12 months, not 6 weeks. The 5 to 10 percent target is durable when the timeline is long.

Allow for plateaus. Weight loss is rarely linear, and body composition can improve (more muscle, less visceral fat) without scale change during the middle months.

Weigh weekly or fortnightly, not daily. Daily weight is mostly noise (fluid shifts, gut contents) and a reliable source of unnecessary distress.

A note on "should I lose weight before TTC at all"

The honest answer depends on BMI and on what else is going on.

For BMI under 30 with regular cycles, weight is often not the primary fertility lever, and addressing thyroid, ferritin, PCOS metabolic markers, or partner factors may be higher yield. The reflexive "lose weight" advice for BMI 27 to 29 is often the wrong target.

For BMI 30 to 40 with anovulation, a 5 to 10 percent reduction is one of the highest-yield interventions available. The evidence is consistent across guidelines and trials.

For age 35 or older, the fertility cost of waiting 12 months to reach a weight target needs to be weighed against the benefit. Sometimes parallel work (starting letrozole-based ovulation induction while continuing the lifestyle work) is the right call. Ask the question directly with your team rather than assuming the only path is weight first, treatment after.

What to do this week

Concrete and proportionate.

1. Calculate 5 percent and 10 percent of your current body weight. Write them down.
2. Pick one anchor behaviour you can imagine doing for a year: a daily 30-minute walk, two short resistance sessions a week, protein and fibre before carbohydrate at meals. Start with one, not three.
3. Adopt one dietary change you can sustain (legumes three times a week, sugary drinks down, protein at breakfast).
4. Sleep 7 to 8 hours. If you cannot, treat that as a separate clinical problem to address (see sleep, stress, and fertility).
5. Skip the supplement aisle. The supplements that work for PCOS metabolism are inositol and (under clinician care) metformin. The rest is marketing.
6. If you have not had metabolic labs in 6 to 12 months, request HbA1c, fasting insulin, fasting glucose, and a 75 g OGTT. See PCOS, insulin resistance, and fertility.

When to involve your clinician

• BMI of 30 or above with PCOS and anovulation. Discuss metformin, inositol, and a referral to a specialist dietitian.
• History of an eating disorder. This needs to be addressed before any structured weight protocol, with a clinician familiar with the area.
• BMI 35 or above with metabolic comorbidity. Discuss medical and possibly surgical weight management alongside the fertility plan.
• Persistent inability to lose weight despite consistent intervention. A broader endocrine workup (thyroid, Cushing's syndrome, obstructive sleep apnoea) is sometimes the missing piece.
• Already on a GLP-1, or considering one, with TTC planned in the next 12 months. Book the conversation with the prescriber now.

This is a topic that carries weight beyond the kilograms. You are not responsible for having PCOS. You are not at fault for the weight pattern that travels with it. The 5 to 10 percent target is not a verdict on your body. It is a number with evidence behind it, and losing weight with PCOS for fertility can be done without punishing the person walking it.

What's next

• If you want the metabolic backbone behind this post: PCOS, insulin resistance, and fertility
• If you want the diet detail: PCOS diet and fertility and the Mediterranean diet and TTC
• If exercise dosing is the next question: exercise and TTC, how much is too much
• If supplements are next: myo-inositol and PCOS and vitamin D and fertility
• If you want the wider BMI / fertility context: weight and fertility: what the numbers actually mean
• If a cycle just did not work and the weight conversation is layered with grief: when a cycle does not work, the feelings

Sources

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
2. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility 2009;92(6):1966-1982. https://doi.org/10.1016/j.fertnstert.2008.09.018
3. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2019;3(3):CD007506. https://doi.org/10.1002/14651858.CD007506.pub4
4. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 2002;13(6):251-257. https://doi.org/10.1016/S1043-2760(02)00612-4
5. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine 2021;384(11):989-1002. https://doi.org/10.1056/NEJMoa2032183
6. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004;351(26):2683-2693. https://doi.org/10.1056/NEJMoa035622
7. Legro RS, Dodson WC, Kris-Etherton PM, et al. Randomized controlled trial of preconception interventions in infertile women with PCOS. Journal of Clinical Endocrinology & Metabolism 2015;100(11):4048-4058. https://doi.org/10.1210/jc.2015-2778